Strategy for utilization of new antiepileptic drugs

Current Opinion in Neurology

Volumn 21, Issue 2, 2008, Pages 167-172

  Ben Menachem, Elinor ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antiepileptic drugs; Children; Efficacy; Elderly; Epilepsy therapy; Side effects; Women

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; FELBAMATE; FOLIC ACID; GABAPENTIN; LAMOTRIGINE; LIVER ENZYME; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

CLINICAL TRIAL; DRESS SYNDROME; DRUG ACTIVITY; DRUG APPROVAL; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG TOLERABILITY; EDEMA; EPILEPSY; FOCAL EPILEPSY; FOOD AND DRUG ADMINISTRATION; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; MONOTHERAPY; MYOCLONUS EPILEPSY; MYOCLONUS SEIZURE; PHYSICIAN; RASH; REVIEW; SEIZURE; SIDE EFFECT; TONIC CLONIC SEIZURE; UNSPECIFIED SIDE EFFECT; VISUAL IMPAIRMENT; WEIGHT GAIN;

AGE FACTORS; AGED; ANTICONVULSANTS; BRAIN; CHILD; DRUG RESISTANCE; EPILEPSY; FEMALE; HUMANS; LIVER; NEUROPHARMACOLOGY; PATIENT SELECTION; PREGNANCY; SEX FACTORS; TREATMENT OUTCOME;

EID: 43149086634     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3282f827f9     Document Type: Review

References (30)

1. Mattson RH, Cramer JA, Collins JF, et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. N Engl J Med 1985; 313:145-151.
2. Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med 2000; 342:314-319.
3. Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 2006; 47:1094-1120.
4. Brodie MJ, Perucca E, Ryvlin P, et al., Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007; 68:402-408. This is the only adequately powered nonequivalence comparative study between a new AED and an old AED. Both drugs demonstrated similar efficacy and frequency of side effects. For both drugs (levetiracetam and carbamazepine-CR) most patients became seizure-free on the lowest dose.
5. Chadwick D, Anhut H, Greiner MJ, et al. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77. Neurology 1998; 51:1282-1288.
6. Chadwick D. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. Lancet 1999; 354:13-19.
7. Kalviainen R, Nousiainen I. Visual field defects with vigabatrin: epidemiology and therapeutic implications. CNS Drugs 2001; 15:217-230.
8. Natsch S, Hekster YA, Keyser A, et al. Newer anticonvulsant drugs: role of pharmacology, drug interactions and adverse reactions in drug choice. Drug Saf 1997; 17:228-240.
9. Arif H, Buchsbaum R, Weintraub D, et al. Comparison and predictors of rash associated with 15 antiepileptic drugs. Neurology 2007; 68:1701-1709. An excellent review of the risk of rash for the major AEDs.
10. Gilliam F, Carter J, Vahle V. Tolerability of antiseizure medications: implications for health outcomes. Neurology 2004; 63 (10 Suppl 4):S9-S12.
11. Privitera MD, Brodie MJ, Mattson RH, et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003; 107:165-175.
12. Saetre E, Perucca E, Isojärvi J, Gjerstad L. LAM 40089 Study Group international multicenter randomized double-blind controlled trial of lamotrigine and sustained-release carbamazepine in the treatment of newly diagnosed epilepsy in the elderly. Epilepsia 2007; 48:1292-1302.
13. Perucca E, Kwan P. Overtreatment in epilepsy: how it occurs and how it can be avoided. CNS Drugs 2005; 19:897-908.
14. Patsalos P, Perucca E. Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2002; 347-356.
15. Wilby J, Kainth A, Hawkins N, et al. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation. Health Technol Assess 2005; 9:1-157.
16. Cramer JA, Ben Menachem E, French J. Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation. Epilepsy Res 2001; 47:17-25.
17. Chaves J, Sander JW. Seizure aggravation in idiopathic generalized epilepsies. Epilepsia 2005; 46 (Suppl 9):133-139.
18. Ben-Zeev B, Watemberg N, Augarten A, et al. Oligohydrosis and hyperthermia: pilot study of a novel topiramate adverse effect. J Child Neurol 2003; 18:254-257.
19. Knudsen JF, Thambi LR, Kapcala LP, Racoosin JA. Oligohydrosis and fever in pediatric patients treated with zonisamide. Pediatr Neurol 2003; 28:184-189.
20. Pack AM, Gidal B, Vazquez B. Bone disease associated with antiepileptic drugs. Cleve Clin J Med 2004; 71 (Suppl 2):S42-S48.
21. Sheth RD, Hermann BP. Bone mineral density with lamotrigine monotherapy for epilepsy. Pediatr Neurol 2007; 37:250-254.
22. Harden CL, Leppik I. Optimizing therapy of seizures in women who use oral contraceptives. Neurology 2006; 67 (12 Suppl 4):S56-S58.
23. Christensen J, Petrenaite V, Atterman J, et al. Oral contraceptives induce lamotrigine metabolism: evidence from a double-blind, placebo-controlled trial. Epilepsia 2007; 48:484-489. This study can influence prescribing practices of contraceptives together with lamotrigine.
24. Vajda FJ, Hitchcock A, Graham J, et al. The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies. Aust N Z J Obstet Gynaecol 2007; 47:468-474. A good comprehensive review of the Australian pregnancy register and its implications especially in the use of valproate in women of childbearing potential.
25. Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia 2005; 46 (Suppl 9):117-124.
26. Meijer WM, de Walle HE, Kerstjens-Frederikse WS, de Jong-van den Berg LT. Folic acid sensitive birth defects in association with intrauterine exposure to folic acid antagonists. Reprod Toxicol 2005; 20:203-207.
27. Morrow J, Russell A, Guthrie E, et al. Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 2006; 77:193-198.
28. Tomson T, Hiilesmaa V. Epilepsy in pregnancy. BMJ 2007; 335:769-773.
29. Rowan AJ, Ramsay RE, Collins JF, et al., VA Cooperative Study 428 Group. New onset geriatric epilepsy: a randomized study of gabapentin, lamotrigine, and carbamazepine. Neurology 2005; 64:1868-1873.
30. Levy RH, Collins C. Risk and predictability of drug interactions in the elderly. Int Rev Neurobiol 2007; 81:235-251. Useful information on drug interactions to consider when treating elderly patients with AEDs.